Recasens Zorzo, C. (2018). Preclinical evaluation of the antitumor activity of a new CXCR4 inhibitor: A novel therapeutic approach in diffuse large B-cell lymphoma.
Citación estilo ChicagoRecasens Zorzo, Clara. Preclinical Evaluation of the Antitumor Activity of a New CXCR4 Inhibitor: A Novel Therapeutic Approach in Diffuse Large B-cell Lymphoma. 2018.
Cita MLARecasens Zorzo, Clara. Preclinical Evaluation of the Antitumor Activity of a New CXCR4 Inhibitor: A Novel Therapeutic Approach in Diffuse Large B-cell Lymphoma. 2018.
Precaución: Estas citas no son 100% exactas.